Symbollon Corp Sample Contracts
LOAN AND SECURITY AGREEMENT, DATED AS OF MARCH 26, 1997, by and between SILICON VALLEY BANK and SYMBOLLON CORPORATIONLoan and Security Agreement • May 13th, 1997 • Symbollon Corp • Biological products, (no disgnostic substances) • California
Standard Contracts
SYMBOLLON CORPORATION STOCK OPTION AGREEMENT UNDER 1993 STOCK OPTION PLAN INCENTIVE STOCK OPTION AGREEMENT entered into by and between Symbollon Corporation, a Delaware corporation with its principal place of business in Framingham, Massachusetts...Stock Option Agreement • January 7th, 2002 • Symbollon Corp • Biological products, (no disgnostic substances)
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 13th, 2004 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Employment Agreement is made as of the 14 day of December, 1999, by and between Symbollon Corporation, a Delaware corporation with its principal place of business at 37 Loring Drive, Framingham, MA 01702...Employment Agreement • March 27th, 2000 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
AMENDED AND RESTATED EMPLOYMENT AGREEMENT This Employment Agreement is made as of the 14 day of December, 1999, by and between Symbollon Corporation, a Delaware corporation with its principal place of business at 37 Loring Drive, Framingham, MA 01702...Employment Agreement • March 27th, 2000 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
Exhibit 10.14 SUBSCRIPTION AGREEMENT THIS SUBSCRIPTION AGREEMENT made as of this 10th day of August, 1999 between Symbollon Corporation, a Delaware corporation with its principal offices at 37 Loring Drive, Framingham, MA 01702 (the "Company"), and...Subscription Agreement • November 10th, 1999 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
Symbollon Pharmaceuticals, Inc. PLACEMENT AGENT AGREEMENT Dated as of: October 1, 2003. The undersigned, Symbollon Pharmaceuticals, Inc., a Delaware corporation (the "COMPANY"), hereby agrees with Park Securities (the "PLACEMENT AGENT") and Dutchess...Placement Agent Agreement • October 17th, 2003 • Symbollon Corp • Biological products, (no disgnostic substances) • Delaware
SYMBOLLON CORPORATION STOCK PURCHASE AGREEMENT This Agreement dated as of August 4, 1997 is entered into by and between Symbollon Corporation, a Delaware corporation, residing at 37 Loring Drive, Framingham, Massachusetts 01702 (the "Company"), and...Stock Purchase Agreement • August 14th, 1997 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
STANDARD FORM COMMERCIAL LEASE Member Greater Boston Real Estate Board 1. PARTIES Pine Street Realty Trust ("LESSOR"), which expression shall include its heirs, successors, and assigns where the context so admits, does hereby lease to Symbollon...Commercial Lease • August 14th, 1997 • Symbollon Corp • Biological products, (no disgnostic substances)
Page - 1Stock Purchase Agreement • November 6th, 1996 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT This Amendment to the Collaboration and License Agreement by and between Oclassen Pharmaceuticals, Inc. and Symbollon Corporation dated as of May 14, 1996 (the "Agreement") is made as of this 14th day...Collaboration and License Agreement • November 14th, 1997 • Symbollon Corp • Biological products, (no disgnostic substances)
SUBSCRIPTION AGREEMENT THIS SUBSCRIPTION AGREEMENT made as of this 1st day of September, 2004 between Symbollon Pharmaceuticals, Inc., a Delaware corporation with its principal offices at 37 Loring Drive, Framingham, MA 01702 (the "Company"), and the...Subscription Agreement • November 8th, 2004 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
INVESTMENT AGREEMENT INVESTMENT AGREEMENT (this "AGREEMENT"), dated as of October 1, 2003 by and between Symbollon Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Dutchess Private Equities Fund, L.P., a Delaware limited partnership...Investment Agreement • October 17th, 2003 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
Registration Rights AgreementRegistration Rights Agreement • November 14th, 2007 • Symbollon Corp • Biological products, (no disgnostic substances) • Delaware
This Registration Rights Agreement (the “Agreement”) is made as of the date set forth below between Symbollon Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and the investors identified on the signature page hereto (“Holders”). Capitalized terms used and not defined herein shall have the respective meanings ascribed to them in the Securities Purchase Agreement dated as of the date hereof by and between the Company and the Holders (the “Purchase Agreement”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • January 6th, 2006 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement is made as of the 3rd day of January, 2006, by and between Symbollon Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 37 Loring Drive, Framingham, MA 01702 (the "Company"), and Paul C. Desjourdy, residing at 25 Eastmount Road, Medfield, MA 02052 (the "Employee").
REGISTRATION RIGHTS AGREEMENT ----------------------------- Registration Rights Agreement (the "Agreement"), dated as of October 1, 2003, by and between Symbollon Pharmaceuticals, Inc., a corporation organized under the laws of State of Delaware, with...Registration Rights Agreement • October 17th, 2003 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
Securities Purchase AgreementSecurities Purchase Agreement • November 14th, 2007 • Symbollon Corp • Biological products, (no disgnostic substances) • Delaware
Unless otherwise requested by the Investors as indicated in a certificate questionnaire substantially in the form of Exhibit B to the Terms and Conditions, certificates representing the Shares and Warrants purchased by the Investors, respectively, will be registered in the Investors’ names and addresses as set forth below.
Exhibit 10.1 LICENSE AND CO-MARKETING AGREEMENT This Agreement, effective on April 12, 2005 ("Effective Date"), is by and between Symbollon Pharmaceuticals, Inc., having a place of business at 37 Loring Drive, Framingham, MA 01702, and its Affiliates...License and Co-Marketing Agreement • May 16th, 2005 • Symbollon Corp • Biological products, (no disgnostic substances) • New York
SALE/LICENSE AGREEMENTSale/License Agreement • December 10th, 2008 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
This Agreement is made as of this 8th day of December, 2008 by and between BioCide Pharma, Inc. ("BioCide") and Symbollon Pharmaceuticals, Inc. ("Symbollon").
STOCK PURCHASE AGREEMENTStock Purchase Agreement • October 12th, 2010 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
This Agreement dated as of October 8, 2010 is entered into by and between Symbollon Pharmaceuticals, Inc., a Delaware corporation, residing at 99 West Street, Suite J, Medfield, Massachusetts 02052 (the “Company”), and Organic Business Alliances, LLC, a Delaware limited liability corporation (“OBA”), residing at 150 Mead Street, Waccabuc, New York 10597 (OBA and any subsequent valid and permitted transferee, shall hereinafter be collectively referred to as the “Purchaser”).
SUBSCRIPTION AGREEMENTSubscription Agreement • January 25th, 2007 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
THIS SUBSCRIPTION AGREEMENT made as of this 29th day of December, 2006 between Symbollon Pharmaceuticals, Inc., a Delaware corporation with its principal offices at 37 Loring Drive, Framingham, MA 01702 (the "Company"), and the undersigned (the "Subscriber").
STOCK PURCHASE AGREEMENTStock Purchase Agreement • December 30th, 2009 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
This Agreement dated as of December 24, 2009 is entered into by and among Symbollon Pharmaceuticals, Inc., a Delaware corporation, residing at 99 West Street, Suite J, Medfield, Massachusetts 02052 (the “Company”), and Ninth Inning Investments, LLC, a Arizona corporation, Vincent Zaldivar, an individual residing at 2728 Brookstone Ct., Las Vegas, Nevada 89117, and their designees (collectively, the “Purchasers”). Certain other terms are defined in Section 8 below.
ContractEmployment Agreement • March 31st, 2008 • Symbollon Corp • Biological products, (no disgnostic substances)
ContractEmployment Agreement • March 31st, 2008 • Symbollon Corp • Biological products, (no disgnostic substances)
DISTRIBUTION AGREEMENTDistribution Agreement • August 14th, 2009 • Symbollon Corp • Biological products, (no disgnostic substances) • California
THIS AGREEMENT is made this 30th day of June, 2009, by and between Symbollon Pharmaceuticals, Inc., a Delaware corporation, with its principal place of business located at 37 Loring Drive, Framingham, Massachusetts 01702 (the "Company") and Integra Labs, Inc., a Florida corporation, with its principal place of business located at 3065 Porter Street Suite 103 Soquel, CA 95073 (the "Distributor").
TERMINATION OF AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 19th, 2008 • Symbollon Corp • Biological products, (no disgnostic substances)
This Termination, dated as of the 16th day of May, 2008, of the Amended and Restated Employment Agreement dated as of January 3, 2006, as amended on February 7, 2008 (the “Agreement”), by and between Symbollon Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 37 Loring Drive, Framingham, MA 01702 (the "Company"), and Jack H. Kessler, residing at 56 Presidential Drive, Southborough, MA 01772 (the "Employee"). Capitalized terms used but not defined herein shall have the meaning as defined in the Agreement. Except as amended below, all terms and conditions of the Agreement shall remain in full force and effect.
STANDARD FORM COMMERCIAL LEASECommercial Lease • May 15th, 2007 • Symbollon Corp • Biological products, (no disgnostic substances)
TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • October 12th, 2010 • Symbollon Corp • Biological products, (no disgnostic substances) • Massachusetts
This Agreement is made as of this 8th day of October, 2010 by and among Organic Business Alliances, LLC (“OBA”), KSIA, LLC ("Kushi") and Symbollon Pharmaceuticals, Inc. ("Symbollon").
andCollaboration and Sale/License Agreement • August 14th, 1997 • Symbollon Corp • Biological products, (no disgnostic substances) • New York
TERMINATION OF AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 19th, 2008 • Symbollon Corp • Biological products, (no disgnostic substances)
This Termination, dated as of the 16th day of May, 2008, of the Amended and Restated Employment Agreement dated as of January 3, 2006, as amended on February 7, 2008 (the “Agreement”), by and between Symbollon Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 37 Loring Drive, Framingham, MA 01702 (the "Company"), and Paul C. Desjourdy, residing at 25 Eastmount Road, Medfield, MA 02052 (the "Employee"). Capitalized terms used but not defined herein shall have the meaning as defined in the Agreement. Except as amended below, all terms and conditions of the Agreement shall remain in full force and effect.